DexCom

DXCMleader

DexCom is a leader in continuous glucose monitoring technology for people with diabetes. Its G7 sensor provides real-time glucose readings and has become the CGM of choice for many endocrinologists.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($4.0B)

Datos estáticos (cargando finanzas en tiempo real…)

US Revenue (65%)

International Revenue (35%)

Composición de segmentos y clientes principales

Detalles del producto

Dexcom G765%

Continuous glucose monitoring sensor for diabetes management

Dexcom ONE+20%

Affordable CGM for broader diabetes population

Stelo15%

Over-the-counter CGM for glucose health and wellness

Relaciones en la Cadena de Suministro

Competidores

Abbott Laboratories

FreeStyle Libre CGM

Impacto: Primary CGM competitor

Socios

Medtronic

CGM integration with insulin pumps

Impacto: Partnership for integrated systems

Clientes Clave

UnitedHealth Group

CGM coverage for insured members

Impacto: $500M+ annually

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de DexCom impulsado por IA.

Información de la Empresa

Sede Central

San Diego, California, USA

Fundación

1999

Empleados

10,000+

Sitio Web

dexcom.com

Estado del sector — 헬스케어

Noticias del sector